Pharma Unlikely to Strike Gold with Vaccine Equities, Financial Crisis A COVID-19 vaccine might not prove to be a watershed moment for the pharmaceutical industry, but there are plenty of other opportunities, Capital Group says Read More
Investing in Global Champions Equities, Innovation, Webinars How can investors navigate global equity markets during this volatile period? What does this mean for globalisation and for long-term investors? Jonathan Knowles shared his perspectives on medical innovation in the context of COVID-19. Read More
Ping An on Factors in China Chief Investment Officers, Emerging Markets, Equities, Factors, Quant & Systematic The Chinese stock market is driven by different quantitative factors than those in the US and Europe, Ping An China Asset Management (Hong Kong) Deputy CIO said. Steve Zhang speaks to us about the companies quant and machine learning strategies. Read More
The Case for Active Engagement Equities, ESG, Women in Finance ESG should not be applied as a blanket screen to simply weed out poorly rated companies, but should be managed actively, where engagement can lead the way to improvements and ultimately to a repricing of a company, Aberdeen Standard Investments says. Read More
Changing Landscape of EM Small Caps Emerging Markets, Equities Emerging market small caps are increasingly professionalising, attracting more experienced management teams who are able to improve margins, cut costs and allocate capital better. We talk to Jerry Zhang and Prashant Paroda of Wells Fargo about the drivers behind this trend. Read More
Courting Controversy in Times of Crisis Equities, Financial Crisis, Women in Finance Every crisis harbours opportunities for those willing to look deeper at the underlying drivers. We talk to MFS Investment Management about some of the most interesting contrarian trades during this pandemic. Read More
AustralianSuper on China A-share Search Asset Owners, Emerging Markets, Equities AustralianSuper has provided an insight into its decision making process for a recent mandate dedicated to China A-shares. Read More
Tech & Healthcare Innovation in Emerging Markets Emerging Markets, Equities, Innovation Pandemics have a way of speeding up change and innovation. We speak to Kunjal Gala at the international business of Federated Hermes about what this means for emerging market equities. Read More
Diversification through China A-shares Emerging Markets, Equities One of the reasons to invest in China A-shares is diversification. So how have these equities held up during the current pandemic-driven financial crisis? We speak to UBS AM’s Geoffrey Wong to find out. Read More
